Dr. Buff Mair is the new CTS Medical Director and replaces Dr. German Leparc who retired at the beginning of 2018. Several of the CTS client forms specify list the Medical Director in the header and these forms will be updated on March 5, 2018. Check out the Communication page for a complete list of forms or by clicking the link below: Communications
Seasonal monitoring of epidemic triggers for West Nile Virus (WNV) NAT tested donations will begin J...
On January 25, 2021, CTS implements the Ortho VIP viral marker testing platform. Conversion from the...
TEMPE, Ariz. (Sept. 8, 2022) — Marion Lanteri, Ph.D., began this week as Creative Testing Solu...
At CTS, we understand the impact converting to the Ortho viral marker platform has on your operation...
On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Ris...
This is the first update to the original CTS communication distributed on July 6th. As previously co...